<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">

<channel>
	<title>Biotech Stocks Blog</title>
	
	<link>http://www.biotechstocksblog.com</link>
	<description />
	<pubDate>Thu, 05 Nov 2009 00:48:25 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.feedburner.com/BiotechStocksBlog" type="application/rss+xml" /><feedburner:emailServiceId>BiotechStocksBlog</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com" /><item>
		<title>Market Access Position with GSK</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/4EsixyBAB4A/</link>
		<comments>http://www.biotechstocksblog.com/2009/11/04/market-access-position-with-gsk/#comments</comments>
		<pubDate>Thu, 05 Nov 2009 00:48:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=801</guid>
		<description>Submitted by Bapcha&amp;#8217;s Stocks
GlaxoSmithKline
Director of Market Access, Dermatology
Research Triangle Park, NC
Company:
GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company. GSK has leadership in four major therapeutic areas - anti-infectives, central nervous system, respiratory, and cardiovascular/metabolic and dermatology. In addition, it is a leader in the important area of vaccines, has a growing portfolio of oncology [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/4EsixyBAB4A" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/11/04/market-access-position-with-gsk/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/11/04/market-access-position-with-gsk/</feedburner:origLink></item>
		<item>
		<title>The Dethroning of the U.S. Dollar Will Happen Sooner Than You Think</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/PfmrKvjWr8Y/</link>
		<comments>http://www.biotechstocksblog.com/2009/11/04/the-dethroning-of-the-us-dollar-will-happen-sooner-than-you-think/#comments</comments>
		<pubDate>Thu, 05 Nov 2009 00:46:41 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=799</guid>
		<description>Submitted by Bapcha&amp;#8217;s Stocks
Filed Under (Brazil, Chicago, China, Coca-Cola, France, GE, Global Reserve Currency, India, Japan, KO, Middle-East, NY, New-York, OIL, Russia, Shanghai, US Dollar, Uncategorized, WMT, WalMart, dethroning) by Bapcha Murty on 04-11-2009
Tagged Under : $, Brazil, Chicago, China, Coca-Cola, dethroning, France, GE, Global Reserve Currency, India, Japan, KO, Middle-East, New-York, NY, OIL, Russia, [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/PfmrKvjWr8Y" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/11/04/the-dethroning-of-the-us-dollar-will-happen-sooner-than-you-think/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/11/04/the-dethroning-of-the-us-dollar-will-happen-sooner-than-you-think/</feedburner:origLink></item>
		<item>
		<title>If You’re Going to Buy a House, Do it Now</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/OTMTYrzVP6Y/</link>
		<comments>http://www.biotechstocksblog.com/2009/11/04/if-you%e2%80%99re-going-to-buy-a-house-do-it-now/#comments</comments>
		<pubDate>Thu, 05 Nov 2009 00:45:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=797</guid>
		<description>Submitted by Bapcha&amp;#8217;s Stocks
Filed Under ($8000, Congress, GS, Goldman-Sachs, Housing, Nov 30 2009, Obama, Tax-credit) by Bapcha Murty on 04-11-2009
Tagged Under : $8000, Congress, Goldman-Sachs, GS, Housing, Nov 30 2009, Obama, Tax-credit 

By Martin Hutchinson Contributing Editor Money Morning
It looks like the U.S. housing sector has bottomed. In fact, if you’ve been thinking about buying [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/OTMTYrzVP6Y" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/11/04/if-you%e2%80%99re-going-to-buy-a-house-do-it-now/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/11/04/if-you%e2%80%99re-going-to-buy-a-house-do-it-now/</feedburner:origLink></item>
		<item>
		<title>Brand new HE&amp;OR and P&amp;R Department - Multiple Locations</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/dX3bpbix7ZY/</link>
		<comments>http://www.biotechstocksblog.com/2009/11/03/brand-new-heor-and-pr-department-multiple-locations/#comments</comments>
		<pubDate>Tue, 03 Nov 2009 14:19:59 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=795</guid>
		<description>Submitted by THE HEALTH ECONOMICS BLOG
Dear All,
this just came in. Please get in touch with Simon.
Cheers
Ulf
Hays Pharma are working exclusively with a top Pharma who looking to start a new department with multiple vacancies in different location.
The positions vacant are:
Director/Senior Manager – Health Economics and Outcomes Research
Region – PECANZ (Europe, Canada, Australia and New Zealand)
Location [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/dX3bpbix7ZY" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/11/03/brand-new-heor-and-pr-department-multiple-locations/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/11/03/brand-new-heor-and-pr-department-multiple-locations/</feedburner:origLink></item>
		<item>
		<title>Anatomy of a Scam: This “Prime Bank Program” Has Already Cost Investors Billions</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/4ILZJqErNVY/</link>
		<comments>http://www.biotechstocksblog.com/2009/10/30/anatomy-of-a-scam-this-%e2%80%9cprime-bank-program%e2%80%9d-has-already-cost-investors-billions/#comments</comments>
		<pubDate>Sat, 31 Oct 2009 02:33:35 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=792</guid>
		<description>Submitted by Bapcha&amp;#8217;s Stocks

By Shah Gilani 
Contributing Editor
Money Morning
Two years ago, an associate of mine lost $100,000 because he didn’t listen to me. A year ago, I saved a manufacturing company from the same scam. And just last week I saved a friend of mine $300,000.
For several years now, a far-fetched but seemingly plausible investment [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/4ILZJqErNVY" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/10/30/anatomy-of-a-scam-this-%e2%80%9cprime-bank-program%e2%80%9d-has-already-cost-investors-billions/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/10/30/anatomy-of-a-scam-this-%e2%80%9cprime-bank-program%e2%80%9d-has-already-cost-investors-billions/</feedburner:origLink></item>
		<item>
		<title>A Money Morning Interview: The Future of Energy</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/KJvnOOzmIls/</link>
		<comments>http://www.biotechstocksblog.com/2009/10/30/a-money-morning-interview-the-future-of-energy/#comments</comments>
		<pubDate>Sat, 31 Oct 2009 02:31:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=790</guid>
		<description>Submitted by Bapcha&amp;#8217;s Stocks

Renowned Oil Expert Dr. Kent Moors Details Shortages of Oil, the Impact of Higher Prices, the Promise of New Technologies and the Opportunities For Investors Dr. Kent Moors is one of the world’s foremost experts on oil, energy policy, finance, risk management and new technologies. Moors advises the leaders of six oil-producing [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/KJvnOOzmIls" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/10/30/a-money-morning-interview-the-future-of-energy/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/10/30/a-money-morning-interview-the-future-of-energy/</feedburner:origLink></item>
		<item>
		<title>Risk sharing workshop @ ISPOR</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/dAaVvTWVPF4/</link>
		<comments>http://www.biotechstocksblog.com/2009/10/30/risk-sharing-workshop-ispor/#comments</comments>
		<pubDate>Fri, 30 Oct 2009 14:57:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=788</guid>
		<description>Submitted by THE HEALTH ECONOMICS BLOG
Dear All,
back from Paris we just wanted to thank all participants for the very positive feedback on our workshop. People really liked the practical approach and the comprehensiveness of the issues to be considered when thinking of setting up a Risk Share agreement. We are also writing up a manuscript [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/dAaVvTWVPF4" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/10/30/risk-sharing-workshop-ispor/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/10/30/risk-sharing-workshop-ispor/</feedburner:origLink></item>
		<item>
		<title>Market Access Seminar in Spain: “Access to market for new drugs. Present and future in our country.” 5 and 6 November. Madrid</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/_3s-cXN1ZP4/</link>
		<comments>http://www.biotechstocksblog.com/2009/09/28/market-access-seminar-in-spain-access-to-market-for-new-drugs-present-and-future-in-our-country-5-and-6-november-madrid/#comments</comments>
		<pubDate>Tue, 29 Sep 2009 01:21:29 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=786</guid>
		<description>Submitted by THE HEALTH ECONOMICS BLOG

PORIB is organizing a conference entitled &amp;#8220;Market access of new drugs&amp;#8221; to be held on 5 and 6 November 2009, in Madrid. The workshop objectives are to review the current status of the criteria and procedures in this area and to determine who will decide the market access of new [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/_3s-cXN1ZP4" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/09/28/market-access-seminar-in-spain-access-to-market-for-new-drugs-present-and-future-in-our-country-5-and-6-november-madrid/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/09/28/market-access-seminar-in-spain-access-to-market-for-new-drugs-present-and-future-in-our-country-5-and-6-november-madrid/</feedburner:origLink></item>
		<item>
		<title>100 Best Blogs for economics students</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/Em1G1BXf-_I/</link>
		<comments>http://www.biotechstocksblog.com/2009/09/24/100-best-blogs-for-economics-students/#comments</comments>
		<pubDate>Fri, 25 Sep 2009 03:11:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=783</guid>
		<description>Submitted by THE HEALTH ECONOMICS BLOG
I received the below article from the administrator of the site and thought that would be interesting to all - especially the students among of you.
&amp;#8220;As an economics student, you have access to a great wealth of information online. One of the best places to find information online is in [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/Em1G1BXf-_I" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/09/24/100-best-blogs-for-economics-students/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/09/24/100-best-blogs-for-economics-students/</feedburner:origLink></item>
		<item>
		<title>How China became the ‘800-Pound’ Gorilla in the Gold Market</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/7Gftogdd6WQ/</link>
		<comments>http://www.biotechstocksblog.com/2009/09/24/how-china-became-the-%e2%80%98800-pound%e2%80%99-gorilla-in-the-gold-market/#comments</comments>
		<pubDate>Fri, 25 Sep 2009 02:55:17 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=780</guid>
		<description>Submitted by Bapcha&amp;#8217;s Stocks
With prices testing their record high of $1,033 an ounce set last year gold has again become the hot topic of conversation.
But while many analysts are focusing on threat of inflation – which could be a byproduct of the U.S. Federal Reserve’s reluctance to withdraw monetary stimulus – investors should really be [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/7Gftogdd6WQ" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/09/24/how-china-became-the-%e2%80%98800-pound%e2%80%99-gorilla-in-the-gold-market/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/09/24/how-china-became-the-%e2%80%98800-pound%e2%80%99-gorilla-in-the-gold-market/</feedburner:origLink></item>
		<item>
		<title>Special Report: How the Government is Setting Us Up for a Second Subprime Crisis</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/dgnKm5JBOpw/</link>
		<comments>http://www.biotechstocksblog.com/2009/09/24/special-report-how-the-government-is-setting-us-up-for-a-second-subprime-crisis/#comments</comments>
		<pubDate>Fri, 25 Sep 2009 02:54:24 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=778</guid>
		<description>Submitted by Bapcha&amp;#8217;s Stocks
Is the government creating another subprime-mortgage bubble?
The first time around, the three-headed federal serpent – the Bush administration, the Treasury Department and the U.S. Federal Reserve – used Fannie Mae (NYSE: FNM) and Freddie Mac (NYSE:FRE) to “legitimize” trillions of dollars worth of toxic financial waste known as subprime mortgages.
The result was [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/dgnKm5JBOpw" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/09/24/special-report-how-the-government-is-setting-us-up-for-a-second-subprime-crisis/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/09/24/special-report-how-the-government-is-setting-us-up-for-a-second-subprime-crisis/</feedburner:origLink></item>
		<item>
		<title>U.S. Trade Spat with China Escalates, But is Unlikely to Cause a Significant Rift</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/Clz6ULSwAzQ/</link>
		<comments>http://www.biotechstocksblog.com/2009/09/24/us-trade-spat-with-china-escalates-but-is-unlikely-to-cause-a-significant-rift/#comments</comments>
		<pubDate>Fri, 25 Sep 2009 02:42:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=775</guid>
		<description>Submitted by Bapcha&amp;#8217;s Stocks
Shortly after U.S. President Barack Obama announced hefty import duties on Chinese-made tires, China’s Ministry of Commerce over the weekend said it would explore possible sanctions against U.S. automobile and chicken imports.
The dispute has caused some concern over an escalation in protectionist measures between the two nations, but few analysts believe the [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/Clz6ULSwAzQ" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/09/24/us-trade-spat-with-china-escalates-but-is-unlikely-to-cause-a-significant-rift/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/09/24/us-trade-spat-with-china-escalates-but-is-unlikely-to-cause-a-significant-rift/</feedburner:origLink></item>
		<item>
		<title>Here’s Why the U.S.-China Tire Tiff Lead to Great Depression II</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/6KEpvcGT1kg/</link>
		<comments>http://www.biotechstocksblog.com/2009/09/24/here%e2%80%99s-why-the-us-china-tire-tiff-lead-to-great-depression-ii/#comments</comments>
		<pubDate>Fri, 25 Sep 2009 02:41:26 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=773</guid>
		<description>Submitted by Bapcha&amp;#8217;s Stocks
When U.S. President Barack Obama late Friday (Sept. 11) signed an order that imposed an additional duty of 35% on tires imported from China, it set up the potential for an old-fashioned trade war.
Currently, global trade is down only 20%. During normal times, worldwide commerce would recover on its own. But as [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/6KEpvcGT1kg" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/09/24/here%e2%80%99s-why-the-us-china-tire-tiff-lead-to-great-depression-ii/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/09/24/here%e2%80%99s-why-the-us-china-tire-tiff-lead-to-great-depression-ii/</feedburner:origLink></item>
		<item>
		<title>The U.S. Housing Market’s False Dawn</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/LmsBnkpZPcs/</link>
		<comments>http://www.biotechstocksblog.com/2009/09/01/the-us-housing-market%e2%80%99s-false-dawn/#comments</comments>
		<pubDate>Wed, 02 Sep 2009 01:45:28 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=771</guid>
		<description>Submitted by Bapcha&amp;#8217;s Stocks
Is the U.S. housing market truly at a turning point, as investors seem to increasingly believe? Or is this actually a false dawn, meaning that there are problems and pain ahead for those who turned bullish too soon?

More on this topic (What&amp;#8217;s this?) 

Why Housing Prices Will Keep Dropping in Value (Investment [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/LmsBnkpZPcs" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/09/01/the-us-housing-market%e2%80%99s-false-dawn/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/09/01/the-us-housing-market%e2%80%99s-false-dawn/</feedburner:origLink></item>
		<item>
		<title>Bank Stock Outlook: Will First-Half Gains Give Way to Second-Half Pain?</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/3phOp_rw1Vc/</link>
		<comments>http://www.biotechstocksblog.com/2009/07/31/bank-stock-outlook-will-first-half-gains-give-way-to-second-half-pain/#comments</comments>
		<pubDate>Fri, 31 Jul 2009 04:00:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=769</guid>
		<description>Submitted by Bapcha&amp;#8217;s Stocks

Posted on July 29th, 2009 in BAC, BB&amp;#38;T Corp, BBT, BK, Bank of America, Bank of New York Mellon, C, COF, Capital One Financial, Citigroup, FTB, Fifth Third, JPM, JPMorgan Chase, PNC, PNC Financial, RF, Regions Financial, STI, STT, State Street Corp., SunTrust, US Bancorp, USB, WFC, Wells Fargo BAC, Bank of [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/3phOp_rw1Vc" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/07/31/bank-stock-outlook-will-first-half-gains-give-way-to-second-half-pain/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/07/31/bank-stock-outlook-will-first-half-gains-give-way-to-second-half-pain/</feedburner:origLink></item>
		<item>
		<title>Four Ways to Profit if Bernanke’s ‘Exit Strategy’ Backfires</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/dniDS0sELq8/</link>
		<comments>http://www.biotechstocksblog.com/2009/07/27/four-ways-to-profit-if-bernanke%e2%80%99s-%e2%80%98exit-strategy%e2%80%99-backfires/#comments</comments>
		<pubDate>Mon, 27 Jul 2009 16:44:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=767</guid>
		<description>Submitted by Bapcha&amp;#8217;s Stocks
BASE, Ben Bernanke, Bernanke, Commercial Paper, ECB, ETF, European Central Bank, FOMC, GLD, OIL, RBS, SPDR Gold, St. Louis Adjusted Monetary Base, TALF, UGA, USO, inflation BASE, Ben Bernanke, Bernanke, Commercial Paper, ECB, ETF, European Central Bank, FOMC, GLD, inflation, OIL, RBS, SPDR Gold, St. Louis Adjusted Monetary Base, TALF, UGA, USO
After [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/dniDS0sELq8" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/07/27/four-ways-to-profit-if-bernanke%e2%80%99s-%e2%80%98exit-strategy%e2%80%99-backfires/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/07/27/four-ways-to-profit-if-bernanke%e2%80%99s-%e2%80%98exit-strategy%e2%80%99-backfires/</feedburner:origLink></item>
		<item>
		<title>The Three Reasons China Will Lead the Global Rebound</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/wsAYrAu_UHU/</link>
		<comments>http://www.biotechstocksblog.com/2009/07/27/the-three-reasons-china-will-lead-the-global-rebound/#comments</comments>
		<pubDate>Mon, 27 Jul 2009 16:42:31 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=765</guid>
		<description>Submitted by Bapcha&amp;#8217;s Stocks
CIT, CIT Group, China, China&amp;#8217;s Opportunity, Dollar, Hu Jintao, Lending, Renminbi, Unemployment, Uyghur Riots, Xinjiang Region, risk China, China&amp;#8217;s Opportunity, CIT, CIT Group, Dollar, Hu Jintao, Lending, Renminbi, risk, Unemployment, Uyghur Riots, Xinjiang Region
Unlike the West – which views the financial crisis as a burden, a mistake, or a bad dream to [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/wsAYrAu_UHU" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/07/27/the-three-reasons-china-will-lead-the-global-rebound/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/07/27/the-three-reasons-china-will-lead-the-global-rebound/</feedburner:origLink></item>
		<item>
		<title>Eight Ways to Profit From Japan’s Game-Changing Election</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/9Z3qOv03GOE/</link>
		<comments>http://www.biotechstocksblog.com/2009/07/24/eight-ways-to-profit-from-japan%e2%80%99s-game-changing-election/#comments</comments>
		<pubDate>Fri, 24 Jul 2009 11:33:09 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=763</guid>
		<description>Submitted by Bapcha&amp;#8217;s Stocks
Circle K Sunkus, E-Trade, ETFC, EWJ, EWJ ETF, Eisai, Elections, Japan, Kao Corp, Kirin, LDP, Liberal Democratic Party, SNE, Seven &amp;#38; I, Showa Sangyo, Sony, Taro Aso, Uncategorized, iSHares Circle K Sunkus, E-Trade, Eisai, Elections, ETFC, EWJ, EWJ ETF, iSHares, Japan, Kao Corp, Kirin, LDP, Liberal Democratic Party, Seven &amp;#38; I, Showa [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/9Z3qOv03GOE" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/07/24/eight-ways-to-profit-from-japan%e2%80%99s-game-changing-election/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/07/24/eight-ways-to-profit-from-japan%e2%80%99s-game-changing-election/</feedburner:origLink></item>
		<item>
		<title>Hot Stocks: Three Reasons Apple is Bucking the Recession</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/XBvyT1jnP7Y/</link>
		<comments>http://www.biotechstocksblog.com/2009/07/24/hot-stocks-three-reasons-apple-is-bucking-the-recession/#comments</comments>
		<pubDate>Fri, 24 Jul 2009 11:31:44 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=761</guid>
		<description>Submitted by Bapcha&amp;#8217;s Stocks
Is high-tech stalwart Apple Inc. (Nasdaq: AAPL) bucking the worst downturn since the Great Depression?
It sure looks that way.

More on this topic (What&amp;#8217;s this?) 

Will There Be Apple Netbook? (LongShortTrader, 7/22/09) 

Apple Stock (Wealth Daily, 7/23/09) 

Hot Stocks: Three Reasons Apple is Bucking the Recession (Money Morning, 7/23/09)&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/XBvyT1jnP7Y" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/07/24/hot-stocks-three-reasons-apple-is-bucking-the-recession/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/07/24/hot-stocks-three-reasons-apple-is-bucking-the-recession/</feedburner:origLink></item>
		<item>
		<title>Airbus Deal Shows Investors That China Profits Are Cleared For Takeoff</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/CunF0Mfrq0A/</link>
		<comments>http://www.biotechstocksblog.com/2009/07/22/airbus-deal-shows-investors-that-china-profits-are-cleared-for-takeoff/#comments</comments>
		<pubDate>Thu, 23 Jul 2009 03:18:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=759</guid>
		<description>Submitted by Bapcha&amp;#8217;s Stocks
A320, Airbus 320, Airbus-SAS, BA, Boeing, China, EADS NV, SABMiller, SBMRY, Sichuan Airlines, Snow Beer A320, Airbus 320, Airbus-SAS, BA, Boeing, China, EADS NV, SABMiller, SBMRY, Sichuan Airlines, Snow Beer
Individual investors who still hold any doubts about Mainland China’s future growth potential should take a long hard look at Airbus SAS, the [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/CunF0Mfrq0A" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/07/22/airbus-deal-shows-investors-that-china-profits-are-cleared-for-takeoff/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/07/22/airbus-deal-shows-investors-that-china-profits-are-cleared-for-takeoff/</feedburner:origLink></item>
		<item>
		<title>How to Profit From China’s “Hot Money” Strategy</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/ZXaHdJwPZ0g/</link>
		<comments>http://www.biotechstocksblog.com/2009/07/21/how-to-profit-from-china%e2%80%99s-%e2%80%9chot-money%e2%80%9d-strategy/#comments</comments>
		<pubDate>Tue, 21 Jul 2009 19:20:27 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=757</guid>
		<description>Submitted by Bapcha&amp;#8217;s Stocks
China, China&amp;#8217;s Foreign Reserves, Dollar, Hot Money, Renminbi, Yuan China, China&amp;#8217;s Foreign Reserves, Dollar, Hot Money, Renminbi, Yuan
China made headlines around the world this week when it revealed that its foreign reserves had eclipsed the $2 trillion market for the first time, rising by a record $178 billion in the second quarter [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/ZXaHdJwPZ0g" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/07/21/how-to-profit-from-china%e2%80%99s-%e2%80%9chot-money%e2%80%9d-strategy/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/07/21/how-to-profit-from-china%e2%80%99s-%e2%80%9chot-money%e2%80%9d-strategy/</feedburner:origLink></item>
		<item>
		<title>Gold as a currency is dead. [Rehash of an older article].</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/dNcq4qfiDB0/</link>
		<comments>http://www.biotechstocksblog.com/2009/07/21/gold-as-a-currency-is-dead-rehash-of-an-older-article/#comments</comments>
		<pubDate>Tue, 21 Jul 2009 19:18:42 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=755</guid>
		<description>Submitted by Bapcha&amp;#8217;s Stocks
DJIA, GLD, Gold, S&amp;#38;P, investment, platinum, silver DJIA, GLD, Gold, investment, platinum, S&amp;#38;P, silver
With the global economy on the mend, could gold be gearing up for another record-setting run? Not a chance says Bapcha. His bottom-line is – wear it, enjoy it, buy it for fun, but do not invest in gold. [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/dNcq4qfiDB0" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/07/21/gold-as-a-currency-is-dead-rehash-of-an-older-article/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/07/21/gold-as-a-currency-is-dead-rehash-of-an-older-article/</feedburner:origLink></item>
		<item>
		<title>With Inflation on the Horizon, Gold Prices are Ready to Rally</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/7ahs9PBld6U/</link>
		<comments>http://www.biotechstocksblog.com/2009/07/21/with-inflation-on-the-horizon-gold-prices-are-ready-to-rally/#comments</comments>
		<pubDate>Tue, 21 Jul 2009 19:16:18 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=753</guid>
		<description>Submitted by Bapcha&amp;#8217;s Stocks
CBO, Congressional Budget Office, GDX, GLD, Geithner, Gold, JP Morgan, JPM, TALF, Timothy Geithner CBO, Congressional Budget Office, GDX, Geithner, GLD, Gold, JP Morgan, JPM, TALF, Timothy Geithner
With the global economy on the mend, could gold be gearing up for another record-setting run? While Jason Simpkins of Money Morning thinks so, we [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/7ahs9PBld6U" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/07/21/with-inflation-on-the-horizon-gold-prices-are-ready-to-rally/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/07/21/with-inflation-on-the-horizon-gold-prices-are-ready-to-rally/</feedburner:origLink></item>
		<item>
		<title>Uk - faster access to innovative drugs?</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/RFJyEjAsKA4/</link>
		<comments>http://www.biotechstocksblog.com/2009/07/15/uk-faster-access-to-innovative-drugs/#comments</comments>
		<pubDate>Thu, 16 Jul 2009 01:44:24 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=751</guid>
		<description>Submitted by THE HEALTH ECONOMICS BLOG
from The Daily Telegraph
Drug industry keen on new NHS trials
Britain&amp;#8217;s drug industry has welcomed Government plans to trial new drugs ahead of approval by the regulatory body as having the potential to deliver &amp;#8220;a truly transformational change&amp;#8221;.
By Graham Ruddick
Published: 6:31PM BST 14 Jul 2009
The Office for Life Sciences (OLS), led [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/RFJyEjAsKA4" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/07/15/uk-faster-access-to-innovative-drugs/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/07/15/uk-faster-access-to-innovative-drugs/</feedburner:origLink></item>
		<item>
		<title>India’s Budgetary Woes Are a Warning to Global Investors</title>
		<link>http://feedproxy.google.com/~r/BiotechStocksBlog/~3/olId1DuMZ30/</link>
		<comments>http://www.biotechstocksblog.com/2009/07/15/india%e2%80%99s-budgetary-woes-are-a-warning-to-global-investors/#comments</comments>
		<pubDate>Thu, 16 Jul 2009 01:43:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.biotechstocksblog.com/?p=749</guid>
		<description>Submitted by Bapcha&amp;#8217;s Stocks

 Uncategorized Global Investing, India
When India unveiled its annual budget on July 6, it immediately caused a sharp drop in the rupee, as well as a 5.8% decline in the benchmark BSE Sensex stock index that had soared 55% so far this year.

More on this topic (What&amp;#8217;s this?) 

Indian CEOs better than their [...]&lt;img src="http://feeds.feedburner.com/~r/BiotechStocksBlog/~4/olId1DuMZ30" height="1" width="1"/&gt;</description>
		<wfw:commentRss>http://www.biotechstocksblog.com/2009/07/15/india%e2%80%99s-budgetary-woes-are-a-warning-to-global-investors/feed/</wfw:commentRss>
		<feedburner:origLink>http://www.biotechstocksblog.com/2009/07/15/india%e2%80%99s-budgetary-woes-are-a-warning-to-global-investors/</feedburner:origLink></item>
	</channel>
</rss>
